HK52990A - 4-aryl-1,4-dihydropyridine-3,5-dicarboxylate derivatives - Google Patents

4-aryl-1,4-dihydropyridine-3,5-dicarboxylate derivatives

Info

Publication number
HK52990A
HK52990A HK529/90A HK52990A HK52990A HK 52990 A HK52990 A HK 52990A HK 529/90 A HK529/90 A HK 529/90A HK 52990 A HK52990 A HK 52990A HK 52990 A HK52990 A HK 52990A
Authority
HK
Hong Kong
Prior art keywords
dihydropyridine
aryl
dicarboxylate derivatives
dicarboxylate
derivatives
Prior art date
Application number
HK529/90A
Other languages
English (en)
Inventor
Claudio Semeraro
Dino Michell
Daniele Pieraccioll
Giovanni Gaviraghi
Allan David Borthwick
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT22383/84A external-priority patent/IT1175620B/it
Priority claimed from IT21460/85A external-priority patent/IT1187678B/it
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of HK52990A publication Critical patent/HK52990A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B2205/00—Fibre drawing or extruding details
    • C03B2205/44—Monotoring or regulating the preform feed rate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK529/90A 1984-08-22 1990-07-12 4-aryl-1,4-dihydropyridine-3,5-dicarboxylate derivatives HK52990A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22383/84A IT1175620B (it) 1984-08-22 1984-08-22 Derivati piridinici
IT21460/85A IT1187678B (it) 1985-07-05 1985-07-05 Procedimento di preparazione di derivati eterociclici

Publications (1)

Publication Number Publication Date
HK52990A true HK52990A (en) 1990-07-20

Family

ID=26327905

Family Applications (1)

Application Number Title Priority Date Filing Date
HK529/90A HK52990A (en) 1984-08-22 1990-07-12 4-aryl-1,4-dihydropyridine-3,5-dicarboxylate derivatives

Country Status (33)

Country Link
US (2) US4801599A (no)
JP (2) JPS6193162A (no)
KR (1) KR920004482B1 (no)
AT (1) AT394042B (no)
AU (1) AU578724B2 (no)
BE (1) BE903103A (no)
BG (1) BG60409B2 (no)
CA (1) CA1268180A (no)
CH (1) CH666684A5 (no)
CS (1) CS403091A3 (no)
CY (1) CY1494A (no)
DE (1) DE3529997C2 (no)
DK (1) DK165949C (no)
ES (5) ES8703839A1 (no)
FI (1) FI81568C (no)
FR (1) FR2569402B1 (no)
GB (1) GB2164336B (no)
GR (1) GR852016B (no)
HK (1) HK52990A (no)
HU (1) HU196754B (no)
IE (1) IE58486B1 (no)
LU (2) LU88267I2 (no)
MX (1) MX159974A (no)
NL (2) NL193065C (no)
NO (2) NO167142C (no)
NZ (1) NZ212895A (no)
PH (1) PH22014A (no)
PT (1) PT81000B (no)
SA (1) SA91120277B1 (no)
SE (1) SE459920B (no)
SG (1) SG40889G (no)
SK (1) SK278327B6 (no)
ZW (1) ZW13185A1 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
FR2586417B1 (fr) * 1985-08-21 1991-08-30 Glaxo Spa Composes heterocycliques, leur preparation et composition pharmaceutique
EP0226271B1 (en) * 1985-08-21 1990-11-22 GLAXO S.p.A. 1,4-dihydropyridine compounds and their preparation and pharmaceutical formulation
IT1204461B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
IT1204462B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
IT1204460B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
IT1233370B (it) * 1988-11-21 1992-03-27 Glaxo Spa Procedimento di preparazione di derivati diidropipiridinici utili nel trattamento di disturbi cardiovascolari
DE69030982T2 (de) 1989-04-27 1997-11-13 Canon Kk Optisches Aufzeichnungsmedium und Verfahren zu seiner Herstellung
US5196529A (en) * 1990-10-09 1993-03-23 Merck & Co., Inc. 2-phenanthrenyl carbapenem intermediates
US5177202A (en) * 1990-10-09 1993-01-05 Merck & Co., Inc. 2-phenanthrenyl-carbapenems
US5132422A (en) * 1990-10-09 1992-07-21 Merck & Co., Inc. 2-naphthyl-carbapenem intermediates
US5132421A (en) * 1990-10-09 1992-07-21 Merck & Co., Inc. 2-naphthyl-carbapenem intermediates
US5144028A (en) * 1990-10-09 1992-09-01 Merck & Co., Inc. 2-(9-fluorenonyl)-carbapenem intermediates
US5356889A (en) * 1990-08-01 1994-10-18 Merck & Co., Inc. 2-(9-fluorenonyl)-carbapenem intermediates
US5208329A (en) * 1990-10-09 1993-05-04 Merck & Co., Inc. 2-biphenyl carbapenem intermediates
IT1244728B (it) * 1991-02-13 1994-08-08 Glaxo Spa Impiego medicamentoso di derivati diidropiridinici
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
WO2000027397A1 (en) * 1998-11-06 2000-05-18 Glaxo Group Limited Antihypertensive medicaments containing lacidipine and telmisartan
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
MXPA05012900A (es) * 2003-05-30 2006-02-22 Ranbaxy Lab Ltd Derivados de pirrol sustituidos.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
RU2007106714A (ru) * 2004-07-26 2008-09-10 Байер Шеринг Фарма Аг (De) Лечение легочной гипертензии путем ингаляции илопростата с препаратом микрочастиц
WO2006113309A1 (en) 2005-04-15 2006-10-26 Dr. Reddy's Laboratories Ltd. Lacidipine particles
US20070043088A1 (en) * 2005-08-16 2007-02-22 Eswaraiah Sajja Process for preparing lacidipine
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2111863B1 (en) 2005-10-26 2012-03-28 Asahi Kasei Pharma Corporation Fasudil in combination with bosentan for the treament of pulmonary arterial hypertension
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
JP2009514851A (ja) * 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
CL2007000667A1 (es) * 2006-03-14 2008-03-14 Ranbaxi Lab Ltd Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
MX2009000439A (es) * 2006-07-14 2009-02-04 Ranbaxy Lab Ltd Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas.
US20080089947A1 (en) * 2006-08-18 2008-04-17 Knox Clayton D Calcium Influx Inhibitors in the Treatment of Ischemia
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8883844B2 (en) 2010-09-24 2014-11-11 Nitrogenix Inc. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
LT2705839T (lt) 2012-09-10 2018-06-11 Rivopharm Sa Farmacinė kompozicija, apimanti lacidipiną ir jos gavimo būdas
KR101695582B1 (ko) 2013-04-17 2017-01-13 화이자 인코포레이티드 심혈관 질환을 치료하기 위한 n-피페리딘-3-일벤즈아미드 유도체
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455945A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines
DE2228363A1 (de) * 1972-06-10 1974-01-03 Bayer Ag 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
DE3018259A1 (de) * 1980-05-13 1981-11-19 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
NO1999007I1 (no) 1999-04-23
FI81568B (fi) 1990-07-31
CA1268180A (en) 1990-04-24
ES552050A0 (es) 1987-09-01
IE58486B1 (en) 1993-09-22
ZW13185A1 (en) 1986-03-19
DK378085D0 (da) 1985-08-20
PH22014A (en) 1988-05-02
DE3529997A1 (de) 1986-03-06
NL980037I2 (nl) 1999-03-01
ES546324A0 (es) 1987-03-01
SE8503888D0 (sv) 1985-08-20
SE459920B (sv) 1989-08-21
CH666684A5 (de) 1988-08-15
SE8503888L (sv) 1986-02-23
NO167142B (no) 1991-07-01
ES8802497A1 (es) 1988-07-01
JPS6193162A (ja) 1986-05-12
SK278327B6 (en) 1996-11-06
GR852016B (no) 1985-12-19
GB8520924D0 (en) 1985-09-25
BE903103A (fr) 1986-02-24
HUT40625A (en) 1987-01-28
ES552048A0 (es) 1987-09-01
FI853206A0 (fi) 1985-08-21
DE3529997C2 (de) 1996-01-18
ES552051A0 (es) 1987-09-01
NL980037I1 (nl) 1999-02-01
ATA245485A (de) 1991-07-15
JPH0550506B2 (no) 1993-07-29
AU4657685A (en) 1986-02-27
FI853206L (fi) 1986-02-23
NO167142C (no) 1991-10-09
MX159974A (es) 1989-10-17
ES8707930A1 (es) 1987-09-01
NL193065B (nl) 1998-05-06
NL8502296A (nl) 1986-03-17
AT394042B (de) 1992-01-27
NL193065C (nl) 1998-09-08
DK165949C (da) 1993-07-05
AU578724B2 (en) 1988-11-03
DK378085A (da) 1986-02-23
IE852054L (en) 1986-02-22
DK165949B (da) 1993-02-15
KR870002073A (ko) 1987-03-28
LU88267I2 (no) 1994-02-03
PT81000B (pt) 1988-03-03
PT81000A (en) 1985-09-01
CS403091A3 (en) 1992-06-17
FR2569402B1 (fr) 1989-09-22
ES8703839A1 (es) 1987-03-01
FI81568C (fi) 1990-11-12
JPS6479152A (en) 1989-03-24
CY1494A (en) 1990-02-16
GB2164336B (en) 1988-06-08
GB2164336A (en) 1986-03-19
ES8707932A1 (es) 1987-09-01
FR2569402A1 (fr) 1986-02-28
SA91120277B1 (ar) 2006-05-15
SG40889G (en) 1989-12-22
US4801599A (en) 1989-01-31
HU196754B (en) 1989-01-30
US5011848A (en) 1991-04-30
LU86047A1 (fr) 1986-02-28
NO853293L (no) 1986-02-24
KR920004482B1 (ko) 1992-06-05
BG60409B2 (bg) 1995-02-28
NZ212895A (en) 1988-07-28
ES8707931A1 (es) 1987-09-01
JPH0686430B2 (ja) 1994-11-02
ES552049A0 (es) 1988-07-01

Similar Documents

Publication Publication Date Title
GB2164336B (en) 4-aryl-1,4-dihydropyridine-3,5-dicarboxylate derivatives
ZA87327B (en) 1,4-dihydropyridines
AU4744985A (en) 1,4-dihydropyridine derivatives
AU541067B2 (en) 2,6-dimethyl-3,5-dicarboxylates-1,4-dihydropyridines
GB2162513B (en) Dihydropyridine derivatives
AU587388B2 (en) 1, 4-dihydropyridines
GR3003468T3 (en) 4-aryl-5-carbamoyl-1,4-dihydropyridines
AU591651B2 (en) 1,4-dihydropyridines
AU4682785A (en) Dihydropyridine derivatives
DK165686D0 (da) 1,4-dihydropyridin-3,5-dicarboxylatderivater
GB2167745B (en) 1,4-dihydropyridines
DE3461086D1 (en) 1,4-dihydropyridine derivatives
GB8530178D0 (en) 1,4-dihydropyridine derivatives
PH21510A (en) Dihydropyridine derivatives
AU575946B2 (en) 1,4-dihydro-2,6-dimethyl-4-(substituted phenyl)- 3,5-dicarboxylate derivatives
AU4368985A (en) 1,4-dihydropyridines
GB2137622B (en) 1,4-dihydropyridine derivatives
IE841888L (en) 1,4-dihydropyridines
AU5326286A (en) 2,6-dialkyl-4-aryl-1,4-dihydropyridine-3,5 dicarboxylate derivatives
IE852976L (en) 1,4-dihydropyridines
IE853097L (en) 1,4-dihydropyridines
IE853094L (en) 1,4-dihydropyridines
IE851601L (en) Dihydropyridine derivatives.
IE851599L (en) Dihydropyridine derivatives.
IE842800L (en) 1,4-dihydropyridine heterocyclics.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20050820